RB1CC1 Activates RB1 Pathway and Inhibits Proliferation and Cologenic Survival in Human Cancer
Tokuhiro Chano, Kaichiro Ikebuchi, Yasuko Ochi et al. · 2010
Read RB1CC1 Activates RB1 Pathway and Inhibits Proliferation and Cologenic Survival in Human Cancer by Tokuhiro Chano, Kaichiro Ikebuchi, Yasuko Ochi et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0011404.txt.
Description
Tokuhiro Chano and colleagues showed in 2010 that a protein called RB1CC1 can switch a key growth brake back on in human cancer cells. The RB1 pathway normally stops cells from dividing without control, and cancers often disable it. Rather than adding a foreign drug, the team raised the level of this built-in activator.
With more RB1CC1, cancer cells grew more slowly and formed far fewer colonies, the lab sign of a tumor's power to spread from single cells. Reactivating a brake the cell already owns is an appealing strategy, since it works with normal control systems. The result names RB1CC1 as both a marker and a possible lever in cancer. Tumors that have lost it may be the ones most in need of drugs that restore the same braking effect.
Catalog record
| CREATOR | Tokuhiro Chano, Kaichiro Ikebuchi, Yasuko Ochi et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011404